These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 21496551

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma.
    Fernández Faith E, Shah S, Witman PM, Harfmann K, Bradley F, Blei F, Pope E, Alsumait A, Gupta D, Covelli I, Streicher JL, Cotton C, Tollefson M, Nguyen H, Hunt R, Moore-Clingenpeel M, Frieden IJ.
    JAMA Dermatol; 2021 May 01; 157(5):566-572. PubMed ID: 33787840
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Topical propranolol therapy for infantile hemangiomas.
    Kunzi-Rapp K.
    Pediatr Dermatol; 2012 May 01; 29(2):154-9. PubMed ID: 22141326
    [Abstract] [Full Text] [Related]

  • 27. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A, D'Erme AM, Zamma Gallarati B, Caputo R, de Martino M.
    Dermatol Ther; 2014 May 01; 27(4):198-202. PubMed ID: 24548454
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases.
    Halilbasic A, Hotic N, Husaric E, Rahmanovic E, Halilbasic M, Husaric S.
    Med Arh; 2011 May 01; 65(6):380-2. PubMed ID: 22299307
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J, Sammour R, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Boutin C, Bortoluzzi P, Laberge LC, Powell J.
    J Cutan Med Surg; 2012 May 01; 16(5):317-23. PubMed ID: 22971306
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Management of ulcers on a segmental hemangioma: A combination of systemic and topical therapies in two pediatric cases].
    Tirelli LL, Luna PC, Panizzardi AA, Larralde M.
    Arch Argent Pediatr; 2022 Oct 01; 120(5):e226-e230. PubMed ID: 36190226
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations].
    Sánchez-Carpintero I, Ruiz-Rodriguez R, López-Gutiérrez JC.
    Actas Dermosifiliogr; 2011 Dec 01; 102(10):766-79. PubMed ID: 21774911
    [Abstract] [Full Text] [Related]

  • 38. Propranolol versus steroids for the treatment of ulcerated infantile hemangiomas.
    Polites SF, Rodrigue BB, Chute C, Hammill A, Dasgupta R.
    Pediatr Blood Cancer; 2018 Oct 01; 65(10):e27280. PubMed ID: 29932302
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Rare complication - skin atrophy - after systemic conservative therapy of infantile hemangioma.
    Chakhunashvili K, Kvirkvelia E, Todua N, Chakhunashvili DG.
    BMC Pediatr; 2024 Feb 23; 24(1):138. PubMed ID: 38395819
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.